Cargando…
Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
The macrophage is a key cell in the pro- and anti-inflammatory response including that of the inflammatory microenvironment of malignant tumors. Much current drug development in chronic inflammatory diseases and cancer therefore focuses on the macrophage as a target for immunotherapy. However, this...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432735/ https://www.ncbi.nlm.nih.gov/pubmed/32752088 http://dx.doi.org/10.3390/ijms21155497 |